Will NYS Miss the Biotech Train?

CGR's Gleason Center for State Policy explored NYS's financial return from investments in biotech R&D. CGR found that investments in biotech are likely to yield a greater economic impact than investments in physical science research.

Report Date: Jun 2001
Author(s): Kent Gardner
Subject(s): Economic Analysis
Location: New York State